Biogen’s Alzheimer’s drug slows cognitive decline in early study – STAT

1. Biogen’s Alzheimer’s drug slows cognitive decline in early study STAT
2. More convenient form of breakthrough Alzheimer’s drug Leqembi shows promising results in study CNBC
3. New studies find benefits in very early drug treatment of Alzheimer’s Financial Times
4. New Data from Biogen’s Investigational Antisense Oligonucleotide (ASO) Targeting Tau Shows Promise for Potential New Generation of Treatments in Early Alzheimer’s Disease | Biogen Biogen
5. Alzheimer’s drug Leqembi could be given as shots rather than IV infusion, study suggests CNN
6. View Full Coverage on Google News

Read original article here